Top Pharmaceuticals companies in Denmark by Current Liabilities

This ranking features the top 15 Pharmaceuticals companies in Denmark ranked by Current Liabilities, totalling a Current Liabilities of USD 30.32 B, for January 15, 2025.
#
Name
Current Liabilities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 25.11 B
Dec. 31, 2023 USD 81.56 -2.90%

Denmark

2
USD 1.52 B
Sept. 30, 2024 USD 109.06 -0.12%

Denmark

3
USD 1.18 B
Dec. 31, 2023 USD 5.46 0.56%

Denmark

4
USD 1.07 B
Dec. 31, 2023 USD 54.16 -1.39%

Denmark

5
USD 412.66 M
Dec. 31, 2023 USD 26.62 -0.36%

Denmark

6
USD 367.68 M
Dec. 31, 2023 USD 216.88 1.28%

Denmark

7
USD 217.82 M
Dec. 31, 2023 USD 131.57 -1.84%

Denmark

8
USD 194.50 M
Dec. 31, 2023 USD 20.15 -0.78%

Denmark

9
USD 158.03 M
Sept. 30, 2024 USD 18.73 1.26%

Denmark

10
USD 42.12 M
Dec. 31, 2023 USD 95.84 0.08%

Denmark

11
USD 14.19 M
June 30, 2024 USD 70.50 0.61%

Denmark

12
USD 12.45 M
Dec. 31, 2023 USD 91.43 -1.85%

Denmark

13
USD 3.76 M
Dec. 31, 2023 USD 0.20 -2.77%

Denmark

14
USD 1.75 M
Dec. 31, 2023 USD 0.57 1.47%

Denmark

15
USD 1.12 M
Dec. 31, 2023 USD 2.17 5.88%

Denmark

Frequently Asked Questions
  • Which Pharmaceuticals company in Denmark has the highest Current Liabilities ?

    The Pharmaceuticals company in Denmark with the highest Current Liabilities is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 25.11 B.

  • Which Pharmaceuticals company in Denmark has the lowest Current Liabilities ?

    The Pharmaceuticals company in Denmark with the lowest Current Liabilities is ExpreS2ion Biotech Holding AB (publ) (Stockholm Stock Exchange: EXPRS2.ST) at USD 1.12 M.